Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use

Samankaltaisia teoksia

• Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
  Tekijä: Duintjer Tebbens, Radboud J., et al.
  Julkaistu: (2018)
• Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
  Tekijä: Duintjer Tebbens, Radboud J., et al.
  Julkaistu: (2016)
• Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers
  Tekijä: Duintjer Tebbens, Radboud J., et al.
  Julkaistu: (2017)
• Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes
  Tekijä: Thompson, Kimberly M., et al.
  Julkaistu: (2017)
• Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
  Tekijä: Thompson, Kimberly M., et al.
  Julkaistu: (2015)